Post

Kymera’s protein degrader starts Phase II trial in atopic dermatitis

Kymera Therapeutics has dosed the first patient in the Phase II ADVANTA trial evaluating KT-474 in patients with atopic dermatitis …

Sanofi’s Phase III multiple myeloma trial meets primary goal

Sanofi has reported that the Phase III IMROZ clinical trial of its monoclonal antibody Sarclisa (isatuximab) plus standard-of-care for multiple …

Harmony Biosciences reports positive Phase II DM1 therapy data

Harmony Biosciences has reported positive topline data from its Phase II clinical trial of pitolisant to treat adults with myotonic …

Halia Therapeutics to test HT-6184 in MDS patients for first time

Halia Therapeutics is looking to start a Phase II trial of its pipeline candidate HT-6184 in myelodysplastic syndrome (MDS) early …

Merck to discontinue Phase III lung cancer trial due to futility

Merck (MSD) has announced plans to discontinue the Phase III KEYLYNK-008 clinical trial of Keytruda plus Lynparza regimen to treat …